NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
0.5860
+0.0050 (0.86%)
At close: Jun 3, 2026, 4:00 PM EDT
0.6037
+0.0177 (3.02%)
Pre-market: Jun 4, 2026, 7:54 AM EDT
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $4.97 million as of June 4, 2026. Its market cap has decreased by -73.08% in one year.
Market Cap
4.97M
Enterprise Value
9.04M
1-Year Change
-73.08%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has decreased from $19.59M to $4.97M, a decrease of -74.65%. That is a compound annual growth rate of -26.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 4.92M | -62.44% |
| Dec 31, 2025 | 13.11M | -60.90% |
| Dec 31, 2024 | 33.53M | 175.32% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
| Dec 22, 2021 | 19.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nephros | 39.94M |
| Milestone Scientific | 34.11M |
| Harvard Bioscience | 28.87M |
| Femasys | 22.82M |
| Retractable Technologies | 20.87M |
| Jin Medical International | 19.10M |
| Bionano Genomics | 13.86M |
| Regentis Biomaterials | 8.44M |